Orfadin Suspension
Product Images NDC 66658-204

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Orfadin (NDC 66658-204). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Swedish Orphan Biovitrum Ab (publ), these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Orf02 0011 01

Chemical structure of nitisinone. The diagram shows the molecular layout and bonding of nitisinone's chemical components as depicted in the image.*

FDA Label Image

Orf02 0011 02

Illustration showing three items: an oral syringe labeled with parts "Black line," "Barrel," and "Plunger," a medicine bottle with a blank white label, and an adapter with a labeled "Ribbed end." This diagram likely demonstrates the components used for dosing and administering a liquid medication suspension.*

FDA Label Image

Orf02 0011 03

An instructional illustration showing a hand holding a small bottle with a child-resistant cap, demonstrating the motion to shake the bottle up and down before use.*

FDA Label Image

Orf02 0011 04

An instructional line drawing showing a person using both hands to twist open the cap of a bottle, indicated by an arrow pointing counterclockwise. The image demonstrates the proper way to open a bottle of oral suspension.*

FDA Label Image

Orf02 0011 05

An instructional illustration showing hands opening a bottle by unscrewing the cap. The bottle appears to be a pharmaceutical suspension container, consistent with oral liquid medication packaging such as ORFADIN (nitisinone) 4 mg/mL suspension.*

FDA Label Image

Orf02 0011 06

An instructional illustration showing a hand holding an oral suspension bottle and shaking it up and down, indicating the bottle should be shaken before use.*

FDA Label Image

Orf02 0011 07

An instructional illustration showing hands holding a bottle and unscrewing the cap. The image features an arrow indicating the direction to twist the cap off, likely demonstrating how to open the ORFADIN 4 mg/mL oral suspension bottle.*

FDA Label Image

Orf02 0011 08

An instructional illustration showing two hands holding a dropper bottle vertically, with an arrow pointing upward underneath, indicating to hold or pull the dropper in an upright position.*

FDA Label Image

Orf02 0011 09

An instructional diagram showing a person preparing an oral suspension by inserting a syringe into a bottle's opening. The image emphasizes correct technique for withdrawing the medication from the bottle.*

FDA Label Image

Orf02 0011 10

An instructional illustration showing a hand holding a bottle upside down with a syringe inserted into its opening. A magnified circular inset highlights particles or granules inside the bottle, indicating the suspension's contents to be drawn up. This image demonstrates how to extract the oral suspension from the bottle using the syringe.*

FDA Label Image

Orf02 0011 11

An instructional diagram showing a hand holding an oral suspension bottle labeled ORFADIN and dispensing the liquid into a syringe. A zoomed inset highlights accurate measurement marks on the syringe, emphasizing doses between 0.5 mL and 1.5 mL.*

FDA Label Image

Orf02 0011 12

An instructional illustration showing two hands preparing an oral suspension medication using a syringe. One hand holds a bottle while the other hand inserts the syringe into the bottle's opening for withdrawal of the liquid. This type of illustration typically demonstrates proper administration technique for oral suspension drugs.*

FDA Label Image

Orf02 0011 13

Instructional illustration showing the administration of an oral suspension medicine using a syringe, where a person receives the medication by mouth.*

FDA Label Image

Orf02 0011 14

An instructional illustration showing two hands holding a bottle with one hand gripping the bottle and the other turning the cap counterclockwise, demonstrating how to open the bottle.*

FDA Label Image

Orf02 0011 15

ORFADIN (nitisinone) 4 mg/mL oral suspension carton label showing a 90 mL bottle. The label states it is for oral use, prescription only, and includes storage instructions to refrigerate prior to first use and store at room temperature up to 60 days after opening. Manufactured by Apotek Produktion & Laboratorier AB, marketed by Sobi, Inc., Swedish Orphan Biovitrum AB.*

FDA Label Image

Orf02 0011 16

Orfadin (nitisinone) oral suspension 4 mg/mL label. The 90 mL product is for oral use and requires refrigeration prior to first use, with storage instructions for after opening. Manufactured by Apotek Produktion & Laboratorier AB, Sweden, and marketed by Sobi, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.